To determine whether GSI could induce inhibition of Notch signalling in CD34+ CML primary cells, the expression of Hes1 was investigated in CD34+ CML primary cells at 72h post-GSI (10 μM) treatment. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.